Northwestern Mutual Wealth Management CO Fibrogen Inc Transaction History

Northwestern Mutual Wealth Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$7.94 - $12.96 $39 - $64	-5 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$12.02 - $16.79 $60 - $83	5 New	5 $0
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $1,426 - $2,563	-46 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $1,706 - $2,252	46 New	46 $2,000
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $1,074 - $1,413	-33 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$23.3 - $45.96 $768 - $1,516	33 New	33 $1,000
Q2 2019 Aug 12, 2019	SELL	$35.13 - $55.53 $667 - $1,055	-19 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$42.83 - $59.91 $42 - $59	1 Added 5.56%	19 $1,000
Q4 2018 Feb 12, 2019	BUY	$37.97 - $60.16 $683 - $1,082	18 New	18 $1,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.